Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the older notices including the government funding lapse notice and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:10:31.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and site status, and bumped the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T00:44:51.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added 'Show glossary' and updated the study results section to display 'Results First Posted' (replacing the 'Estimated' variant), along with 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and updated the No FEAR Act data labeling and the site revision to v3.4.0.
    Difference
    0.4%
    Check dated 2026-01-28T00:26:44.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be a metadata/version update with no impact on the study details or user actions.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:14.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Results posting dates and status were added (e.g., Results First Submitted/Posted dates) and a study protocol/SAP PDF was linked; several outcome items were revised or removed in the results section (e.g., Two-year Progression Free Survival and mucositis-related adverse events).
    Difference
    3%
    Check dated 2025-12-30T19:39:44.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Footer revision tag updated to 'Revision: v3.3.3'. The HHS Vulnerability Disclosure link was removed, along with the previous 'Revision: v3.3.2' entry.
    Difference
    0.1%
    Check dated 2025-12-23T14:26:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.